Postmenopausal women who use testosterone therapy could face an increased risk of cardiovascular problems, according to recent research. This study was presented at The Menopause Society’s 2026 annual meeting in San Diego and involved over 6,000 women aged 45 and older. These women were compared based on whether they received testosterone therapy or not, excluding those with a history of cardiovascular disease.
Findings indicate that among women receiving testosterone, 3.8% experienced a first-time cardiovascular event, while only 0.5% of women not receiving the treatment had such events. The cardiovascular issues reported included heart attacks, strokes, heart failure, and other related problems.
Testosterone is a hormone produced by the ovaries and adrenal glands that influences sexual desire, muscle and bone health, mood, and cognition. Despite potential benefits, testosterone therapy in postmenopausal women could contribute to heart attack, stroke, and other cardiovascular risks.
Anna Cabeca, a Dallas-based board-certified OB-GYN and menopause specialist, highlighted the significance of the data, noting the need to analyze what these numbers convey. While not part of the study, Cabeca emphasized the importance of examining patients’ overall health, including heart history, blood pressure, cholesterol, metabolic health, medications, and family history before considering testosterone therapy.
The study identified approximately 38 cardiovascular events per 1,000 women on testosterone therapy versus five per 1,000 not receiving treatment. Cabeca stressed the need to seriously address women’s sexual health concerns during and after menopause. She notes that potential benefits should be considered alongside risks.
When testosterone therapy is deemed suitable, Cabeca supports careful dosing and regular monitoring of symptoms and lab results.
However, researchers acknowledged limitations in the study. Being observational, it focused on women already receiving testosterone and did not assign treatment in a controlled trial. Hence, while a link between testosterone use and cardiovascular events can be established, causation is not proven.
Differences among women who did and did not receive testosterone could involve age, blood pressure, diabetes, cholesterol, and other health factors impacting heart risk. Cabeca suggests these findings are a safety signal warranting further investigation, not conclusive evidence of causation.
